SynthesisMedicine2018

FOLFOX plus anti-epidermal growth factor receptor (EGFR) monoclonal antibody (mAb) is an effective first-line treatment for patients with RAS-wild left-sided metastatic colorectal cancer: A meta-analysis.

Datian Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.